Unique collaboration with Lille University Hospital

In collaboration with the Clinical Investigation Center of the Lille University Hospital, we are conducting Phase I clinical trials for pharmaceutical companies. For example, we have achieved a Phase I study with a new-class chemical compound, the potential indication of which would be ulcerative colitis.

Partnership with private doctors

We are also cooperating with a regional network of gastroenterologists who are practicing in private offices to recruit IBD or IBS patients to be involved in clinical trials – either for pharmaceutical companies or food ingredients companies. IBS patients are targeted for promising probiotics to be launched in the market in the future.